Azee
Indicated to address localised bacterial pathogens to manage urogenital tissue infections and alleviate pelvic discomfort.
- Category
- Bladder Health
- Active ingredient
- Azithromycin
- Route
- Oral use
- Form
- Tablet
- Strengths
- 250mg · 500mg · 1000mg
Prescription and consultation requirements for Azee vary by destination and are determined by the fulfilment partner.
Azee details
- Conditions
- Bacterial Infections · Chlamydia Trachomatis Infection · Urethritis
- Alternative names
- azithromycin
- Therapeutic class
- Macrolide Antibiotic
- Pharmacological class
- Protein Synthesis Inhibitor
- Known off-label uses
- traveler's diarrhoea
- Contraindications
- history of cholestatic jaundice; hypersensitivity to azithromycin
- Minor side effects
- nausea; vomiting; diarrhoea
- Moderate side effects
- abdominal pain; headache; hearing impairment
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Cipla Ltd
- Onset Time
- 2–4 hours
- Duration
- 2–4 days
- Storage instructions
- Store below 30°C.
- Drug interactions
- Warfarin; Digoxin; Antacids
- Age restrictions
- Approved for paediatric and adult populations.
Serious side effects
QT prolongation, requires immediate medical attention; anaphylaxis, requires immediate medical attention
Patient summary
indicated to address localised bacterial pathogens to manage urogenital tissue infections and alleviate pelvic discomfort.
Mechanism of action
Binds to the 50S ribosomal subunit of susceptible microorganisms, inhibiting protein synthesis and bacterial cell growth.
Pregnancy and breastfeeding
TGA Category B: No evidence of fetal harm in animal models. Breastfeeding: Compatible.